FHTX - CIK 0001822462
Foghorn Therapeutics Inc. has filed 339 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (116 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-14 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| Annual report to shareholders | ARS | 2026-04-30 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-30 | - |
| Proxy statement | DEF 14A | 2026-04-30 | 2026-06-24 |
| Major company event | 8-K | 2026-04-21 | 2026-04-21 |
| Insider trade | 4 | 2026-04-13 | 2026-04-09 |
| Employee stock plan | S-8 | 2026-03-26 | - |
| Annual report | 10-K | 2026-03-11 | 2025-12-31 |
| Major company event | 8-K | 2026-03-11 | 2026-03-11 |
| Insider trade | 4 | 2026-02-24 | 2026-02-23 |
| New insider ownership | 3 | 2026-02-24 | 2026-02-23 |
| Major company event | 8-K | 2026-02-23 | 2026-02-23 |
| Insider trade | 4 | 2026-02-06 | 2026-02-05 |
| Insider trade | 4 | 2026-02-02 | 2026-01-30 |
| Insider trade | 4 | 2026-02-02 | 2026-01-30 |
| Insider trade | 4 | 2026-02-02 | 2026-01-30 |
| Insider trade | 4 | 2026-02-02 | 2026-01-30 |
| Insider trade | 4 | 2026-02-02 | 2026-01-30 |
| Insider trade | 4 | 2026-01-15 | 2026-01-13 |
| SCHEDULE 13D/A | - | 2026-01-13 | - |
| Prospectus supplement | 424B5 | 2026-01-12 | - |
| Major company event | 8-K | 2026-01-12 | 2026-01-09 |
| Major company event | 8-K | 2025-12-04 | 2025-12-03 |
| Insider trade | 4 | 2025-11-17 | 2025-11-14 |
| Major company event | 8-K | 2025-11-07 | 2025-11-07 |
| Quarterly report | 10-Q | 2025-11-05 | 2025-09-30 |
| Major company event | 8-K | 2025-11-05 | 2025-11-05 |
| Major company event | 8-K | 2025-10-30 | 2025-10-30 |
| Major company event | 8-K | 2025-09-02 | 2025-09-02 |
| Quarterly report | 10-Q | 2025-08-05 | 2025-06-30 |
| Major company event | 8-K | 2025-08-05 | 2025-08-05 |
| Major company event | 8-K | 2025-07-01 | 2025-06-27 |
| Major company event | 8-K | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-17 | 2025-06-17 |
| Quarterly report | 10-Q | 2025-05-14 | 2025-03-31 |
| Major company event | 8-K | 2025-05-14 | 2025-05-14 |
| Annual report to shareholders | ARS | 2025-05-05 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-05-05 | - |
| Proxy statement | DEF 14A | 2025-05-05 | 2025-06-17 |
| Insider trade | 4 | 2025-05-02 | 2025-05-01 |